$CLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CORE LABORATORIES N V.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CORE LABORATORIES N V. Get notifications about new insider transactions in CORE LABORATORIES N V for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2014 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 13,622 | 0 | 0 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 190.95 | 5,715 | 1,091,279 | 142,317 | 148 K to 142.3 K (-3.86 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 13,622 | 0 | 148,032 | 134.4 K to 148 K (+10.13 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 3,500 | 0 | 0 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 190.95 | 1,060 | 202,407 | 17,284 | 18.3 K to 17.3 K (-5.78 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 3,500 | 0 | 18,344 | 14.8 K to 18.3 K (+23.58 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | M | 0.00 | 30,635 | 0 | 0 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Payment of Exercise | F | 190.95 | 12,852 | 2,454,089 | 217,284 | 230.1 K to 217.3 K (-5.58 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Buy | M | 0.00 | 30,635 | 0 | 230,136 | 199.5 K to 230.1 K (+15.36 %) |
Oct 23 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 198.11 | 1,414 | 280,128 | 134,410 | 135.8 K to 134.4 K (-1.04 %) |
Oct 23 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 197.23 | 3,070 | 605,487 | 135,824 | 138.9 K to 135.8 K (-2.21 %) |
Oct 23 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 196.71 | 1,220 | 239,983 | 138,894 | 140.1 K to 138.9 K (-0.87 %) |
Aug 07 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Sell | S | 150.11 | 3,000 | 450,320 | 38,853 | 41.9 K to 38.9 K (-7.17 %) |
Aug 07 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Sell | S | 149.58 | 15,200 | 2,273,608 | 41,853 | 57.1 K to 41.9 K (-26.64 %) |
Aug 07 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Sell | S | 148.75 | 1,800 | 267,747 | 57,053 | 58.9 K to 57.1 K (-3.06 %) |
Jul 25 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Sell | S | 147.53 | 7,400 | 1,091,722 | 37,174 | 44.6 K to 37.2 K (-16.60 %) |
Jul 25 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Sell | S | 148.25 | 3,948 | 585,291 | 44,574 | 48.5 K to 44.6 K (-8.14 %) |
Jul 25 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Sell | S | 149.00 | 300 | 44,700 | 48,522 | 48.8 K to 48.5 K (-0.61 %) |
Jul 25 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 150.00 | 1,599 | 239,850 | 140,114 | 141.7 K to 140.1 K (-1.13 %) |
Jul 25 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 149.30 | 1,471 | 219,620 | 141,713 | 143.2 K to 141.7 K (-1.03 %) |
Jul 25 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Sell | S | 148.54 | 2,878 | 427,498 | 143,184 | 146.1 K to 143.2 K (-1.97 %) |
Jul 02 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 1,000 | 0 | 2,000 | |
Jul 02 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 151.66 | 274 | 41,555 | 14,844 | 15.1 K to 14.8 K (-1.81 %) |
Jul 02 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 1,000 | 0 | 15,118 | 14.1 K to 15.1 K (+7.08 %) |
May 20 2013 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
May 20 2013 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
May 01 2013 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
May 01 2013 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
May 01 2013 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
May 01 2013 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
May 01 2013 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 1,088 | 0 | 1,088 | |
Apr 24 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | J | 0.00 | 3,992 | 0 | 0 | |
Apr 24 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | P | 142.58 | 100 | 14,258 | 14,118 | 14 K to 14.1 K (+0.71 %) |
Apr 03 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 700 | 0 | 700 | |
Apr 03 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 134.12 | 192 | 25,751 | 14,018 | 14.2 K to 14 K (-1.35 %) |
Apr 03 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 700 | 0 | 14,210 | 13.5 K to 14.2 K (+5.18 %) |
Apr 03 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 700 | 0 | 700 | |
Apr 03 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 134.12 | 192 | 25,751 | 48,822 | 49 K to 48.8 K (-0.39 %) |
Apr 03 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 700 | 0 | 49,014 | 48.3 K to 49 K (+1.45 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 200 | 0 | 0 | |
Mar 05 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 136.38 | 66 | 9,001 | 13,510 | 13.6 K to 13.5 K (-0.49 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 200 | 0 | 13,576 | 13.4 K to 13.6 K (+1.50 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 400 | 0 | 0 | |
Mar 05 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 136.38 | 131 | 17,866 | 48,314 | 48.4 K to 48.3 K (-0.27 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 400 | 0 | 48,445 | 48 K to 48.4 K (+0.83 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,200 | 0 | 0 | |
Mar 05 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 136.38 | 608 | 82,919 | 146,062 | 146.7 K to 146.1 K (-0.41 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 2,200 | 0 | 146,670 | 144.5 K to 146.7 K (+1.52 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 2,200 | 0 | 0 | |
Mar 05 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 136.38 | 614 | 83,737 | 58,853 | 59.5 K to 58.9 K (-1.03 %) |
Mar 05 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 2,200 | 0 | 59,467 | 57.3 K to 59.5 K (+3.84 %) |
Feb 15 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 26 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 10 | 0 | 3,992 | |
Feb 15 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 15 2013 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 29,218 | 0 | 29,218 | |
Feb 15 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 11,721 | 0 | 11,721 | |
Feb 05 2013 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Sell | S | 137.02 | 700 | 95,911 | 11,823 | 12.5 K to 11.8 K (-5.59 %) |
Feb 05 2013 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Sell | S | 136.65 | 4,000 | 546,579 | 12,523 | 16.5 K to 12.5 K (-24.21 %) |
Feb 05 2013 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Sell | S | 135.37 | 3,300 | 446,705 | 16,523 | 19.8 K to 16.5 K (-16.65 %) |
Feb 15 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | A | 0.00 | 11,721 | 0 | 11,721 | |
Feb 05 2013 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 135.10 | 3,500 | 472,850 | 12,361 | 15.9 K to 12.4 K (-22.07 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 4,800 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 109.31 | 1,750 | 191,293 | 48,045 | 49.8 K to 48 K (-3.51 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 4,800 | 0 | 49,795 | 45 K to 49.8 K (+10.67 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 4,800 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 109.31 | 1,750 | 191,293 | 13,376 | 15.1 K to 13.4 K (-11.57 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 4,800 | 0 | 15,126 | 10.3 K to 15.1 K (+46.48 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 109.31 | 4,374 | 478,122 | 144,470 | 148.8 K to 144.5 K (-2.94 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 12,000 | 0 | 148,844 | 136.8 K to 148.8 K (+8.77 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 109.31 | 4,374 | 478,122 | 60,267 | 64.6 K to 60.3 K (-6.77 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 12,000 | 0 | 64,641 | 52.6 K to 64.6 K (+22.80 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | M | 0.00 | 27,600 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Payment of Exercise | F | 109.31 | 10,061 | 1,099,768 | 199,501 | 209.6 K to 199.5 K (-4.80 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Buy | M | 0.00 | 27,600 | 0 | 209,562 | 182 K to 209.6 K (+15.17 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | M | 0.00 | 1,530 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Payment of Exercise | F | 109.31 | 12 | 1,312 | 47,814 | 47.8 K to 47.8 K (-0.03 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Buy | M | 0.00 | 1,530 | 0 | 47,826 | 46.3 K to 47.8 K (+3.30 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | M | 0.00 | 1,530 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Payment of Exercise | F | 109.31 | 13 | 1,421 | 37,825 | 37.8 K to 37.8 K (-0.03 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Buy | M | 0.00 | 1,530 | 0 | 37,838 | 36.3 K to 37.8 K (+4.21 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | M | 0.00 | 1,530 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Payment of Exercise | F | 109.31 | 3 | 328 | 15,861 | 15.9 K to 15.9 K (-0.02 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Buy | M | 0.00 | 1,530 | 0 | 15,864 | 14.3 K to 15.9 K (+10.67 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Option Exercise | M | 0.00 | 1,530 | 0 | 0 | |
Jan 02 2013 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Payment of Exercise | F | 109.31 | 11 | 1,202 | 19,823 | 19.8 K to 19.8 K (-0.06 %) |
Jan 02 2013 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Buy | M | 0.00 | 1,530 | 0 | 19,834 | 18.3 K to 19.8 K (+8.36 %) |
Dec 03 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 400 | 0 | 0 | |
Dec 03 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 103.18 | 106 | 10,937 | 10,326 | 10.4 K to 10.3 K (-1.02 %) |
Dec 03 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 400 | 0 | 10,432 | 10 K to 10.4 K (+3.99 %) |
Nov 21 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 11 | 0 | 3,982 | |
Aug 22 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 9 | 0 | 3,971 | |
Jul 26 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | M | 0.00 | 2,314 | 0 | 0 | |
Jul 26 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Payment of Exercise | F | 114.45 | 6 | 687 | 36,308 | 36.3 K to 36.3 K (-0.02 %) |
Jul 26 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Buy | M | 0.00 | 2,314 | 0 | 36,314 | 34 K to 36.3 K (+6.81 %) |
Jul 25 2012 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | M | 0.00 | 2,314 | 0 | 0 | |
Jul 25 2012 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Payment of Exercise | F | 114.45 | 5 | 572 | 46,296 | 46.3 K to 46.3 K (-0.01 %) |
Jul 25 2012 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Buy | M | 0.00 | 2,314 | 0 | 46,301 | 44 K to 46.3 K (+5.26 %) |
Jul 25 2012 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | M | 0.00 | 2,314 | 0 | 0 | |
Jul 25 2012 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Payment of Exercise | F | 114.45 | 2 | 229 | 14,334 | 14.3 K to 14.3 K (-0.01 %) |
Jul 25 2012 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Buy | M | 0.00 | 2,314 | 0 | 14,336 | 12 K to 14.3 K (+19.25 %) |
Jul 25 2012 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Option Exercise | M | 0.00 | 2,314 | 0 | 0 | |
Jul 25 2012 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Payment of Exercise | F | 114.45 | 6 | 687 | 18,304 | 18.3 K to 18.3 K (-0.03 %) |
Jul 25 2012 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Buy | M | 0.00 | 2,314 | 0 | 18,310 | 16 K to 18.3 K (+14.47 %) |
Jul 02 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Jul 02 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 115.90 | 265 | 30,714 | 10,032 | 10.3 K to 10 K (-2.57 %) |
Jul 02 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 1,000 | 0 | 10,297 | 9.3 K to 10.3 K (+10.76 %) |
May 31 2012 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
May 29 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 8 | 0 | 3,962 | |
May 17 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 1,000 | 0 | 0 | |
May 17 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 136.56 | 265 | 36,188 | 44,995 | 45.3 K to 45 K (-0.59 %) |
May 17 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 1,000 | 0 | 45,260 | 44.3 K to 45.3 K (+2.26 %) |
May 17 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
May 17 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 136.56 | 729 | 99,552 | 136,844 | 136.1 K to 136.8 K (+0.54 %) |
May 17 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 2,000 | 0 | 137,573 | 135.6 K to 137.6 K (+1.48 %) |
May 17 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
May 17 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 136.56 | 729 | 99,552 | 52,641 | 53.4 K to 52.6 K (-1.37 %) |
May 17 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 2,000 | 0 | 53,370 | 51.4 K to 53.4 K (+3.89 %) |
Apr 27 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Sell | S | 130.85 | 800 | 104,682 | 44,260 | 45.1 K to 44.3 K (-1.78 %) |
Apr 27 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Sell | S | 131.53 | 8,500 | 1,118,042 | 45,060 | 53.6 K to 45.1 K (-15.87 %) |
Apr 27 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Sell | S | 132.13 | 700 | 92,490 | 53,560 | 54.3 K to 53.6 K (-1.29 %) |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 700 | 0 | 1,400 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 131.57 | 186 | 24,472 | 9,297 | 9.5 K to 9.3 K (-1.96 %) |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 700 | 0 | 9,483 | 8.8 K to 9.5 K (+7.97 %) |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 700 | 0 | 1,400 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 131.57 | 186 | 24,472 | 54,260 | 54.4 K to 54.3 K (-0.34 %) |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 700 | 0 | 54,446 | 53.7 K to 54.4 K (+1.30 %) |
Apr 03 2012 | CLB | CORE LABORATORIES ... | VRIESENDORP ALEXANDER | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | Perna Joseph R | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
Apr 03 2012 | CLB | CORE LABORATORIES ... | JOYCE RENE R | Director | Option Exercise | A | 0.00 | 1,141 | 0 | 1,141 | |
Mar 05 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 400 | 0 | 400 | |
Mar 05 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 124.10 | 122 | 15,140 | 53,746 | 53.9 K to 53.7 K (-0.23 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 400 | 0 | 53,868 | 53.5 K to 53.9 K (+0.75 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 200 | 0 | 200 | |
Mar 05 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 124.10 | 62 | 7,694 | 8,783 | 8.8 K to 8.8 K (-0.70 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 200 | 0 | 8,845 | 8.6 K to 8.8 K (+2.31 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,200 | 0 | 2,200 | |
Mar 05 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 124.10 | 593 | 73,591 | 135,573 | 136.2 K to 135.6 K (-0.44 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 2,200 | 0 | 136,166 | 134 K to 136.2 K (+1.64 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 2,200 | 0 | 2,200 | |
Mar 05 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 124.10 | 582 | 72,226 | 51,370 | 52 K to 51.4 K (-1.12 %) |
Mar 05 2012 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 2,200 | 0 | 51,952 | 49.8 K to 52 K (+4.42 %) |
Feb 27 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 9 | 0 | 3,954 | |
Feb 21 2012 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 122.48 | 2,000 | 244,949 | 12,022 | 14 K to 12 K (-14.26 %) |
Feb 17 2012 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | Chief Accounting Of ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 17 2012 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 |